Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-11

Clinical Trial Update: Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation

View source ↗

Summary

This clinical trial update describes the investigation of how ventricular tachycardia ablation may modify rhythmic risk assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Ventricular Tachycardia | Status: UNKNOWN